NCT04558216View on ClinicalTrials.gov

Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2020

Primary Completion Date

February 7, 2021

Study Completion Date

February 19, 2021

Conditions
Healthy Participants
Interventions
DRUG

Vonoprazan

20 mg tablets administered orally

DRUG

Rifampin

600 mg (Two 300 mg capsules)

Trial Locations (1)

78744

PPD Development, LP, 7551 Metro Center Drive, Suite 200, Austin

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY